Clinical trial

Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children

NCT00405522 · The Hospital for Sick Children, Other · Completed

Key facts

NCT number NCT00405522
Title Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children
Official title Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children: Evaluation of Two Dose Combinations
Lead sponsor The Hospital for Sick Children, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Spinal Puncture
Intervention type Drug
Interventions Propofol 2.0 mg/kg + Remifentanil 1.5 ug/kg, Propofol 4.0 mg/kg + Remifentanil 0.5 ug/kg
Enrollment 34
Start date Nov 1, 2006
Primary completion Jun 1, 2007
Completion Jun 1, 2007
First posted Nov 30, 2006
Last update posted Mar 8, 2019
Countries Canada

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies